For what duration must manufacturers maintain records of drug samples?

Manufacturers are required to maintain records of drug samples for three years. This duration aligns with the regulations set forth by the FDA and other governing bodies that oversee the distribution and handling of drug samples. The three-year record retention requirement is designed to ensure adequate oversight and accountability in the distribution of pharmaceutical samples, allowing for proper audits and inspections if necessary. This timeframe provides a sufficient window to track the movement and utilization of drug samples within the healthcare system, as well as to fulfill any legal or regulatory inquiries that may arise.